Hikal Limited (BOM:524735)
India · Delayed Price · Currency is INR 155.90
-9.65 (-5.83%)
At close: Mar 27, 2026
Hikal Market Cap
Hikal has a market cap or net worth of 19.22 billion as of March 27, 2026. Its market cap has decreased by -56.81% in one year.
Market Cap
19.22B
Enterprise Value
25.86B
Revenue
17.46B
Ranking
n/a
PE Ratio
n/a
Stock Price
155.90
Market Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 19.22B, an increase of 1,316.33%. That is a compound annual growth rate of 11.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 20.41B | -27.04% |
| Dec 31, 2025 | 27.98B | -41.82% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 28.18B |
| Novartis India | 22.61B |
| Bliss GVS Pharma | 21.84B |
| Unichem Laboratories | 21.05B |
| Morepen Laboratories | 20.03B |
| Shukra Pharmaceuticals | 15.60B |
| Amrutanjan Health Care | 15.33B |
| Kwality Pharmaceuticals | 15.19B |